甲状腺疾病的细胞与分子生物学。
Cell and Molecular Biology of Thyroid Disorders.
机构信息
Department of Biomedicine, Pharmacology, Aarhus University, Wilhelm Meyers Allé 4, 8000 Aarhus C, Denmark.
University Clinic for Plastic, Aesthetic and Hand Surgery, Otto von Guericke University, Leipziger Str. 44, 39120 Magdeburg, Germany.
出版信息
Int J Mol Sci. 2019 Jun 13;20(12):2895. doi: 10.3390/ijms20122895.
Abstract
The thyroid is a hormone gland involved in metabolism, regulatory functions, growth, and development of the human organism [...].
摘要
甲状腺是一种参与新陈代谢、调节功能、生长和人类机体发育的激素腺[...]。
相似文献
1
Cell and Molecular Biology of Thyroid Disorders.甲状腺疾病的细胞与分子生物学。
Int J Mol Sci. 2019 Jun 13;20(12):2895. doi: 10.3390/ijms20122895.
2
Genetic disorders of thyroid metabolism and brain development.甲状腺代谢与脑发育的遗传性疾病。
Dev Med Child Neurol. 2014 Jul;56(7):627-34. doi: 10.1111/dmcn.12445. Epub 2014 Mar 26.
3
Cell and Molecular Biology of Thyroid Disorders 2.0.甲状腺疾病的细胞与分子生物学 2.0 版。
Int J Mol Sci. 2021 Feb 17;22(4):1990. doi: 10.3390/ijms22041990.
4
Molecular genetic alterations of FHIT and p53 genes in benign and malignant thyroid gland lesions.甲状腺良恶性病变中FHIT和p53基因的分子遗传学改变
Mutat Res. 2006 Jul 25;599(1-2):45-57. doi: 10.1016/j.mrfmmm.2006.01.021. Epub 2006 May 15.
5
[Inherited disorders of thyroid hormone action].[甲状腺激素作用的遗传性疾病]
Harefuah. 1986 Nov 16;111(10):320-3.
6
The role of oxidative stress in physiological and pathological processes in the thyroid gland; possible involvement in pineal-thyroid interactions.氧化应激在甲状腺生理和病理过程中的作用；可能参与松果体-甲状腺相互作用。
Neuro Endocrinol Lett. 2003 Oct;24(5):293-303.
7
Ploidy levels in nonneoplastic and neoplastic thyroid cells.非肿瘤性和肿瘤性甲状腺细胞中的倍体水平。
Anal Quant Cytol Histol. 1985 Jun;7(2):97-106.
8
Proteome analysis in thyroid pathology.甲状腺病理学中的蛋白质组分析。
Expert Rev Proteomics. 2015 Aug;12(4):375-90. doi: 10.1586/14789450.2015.1062369. Epub 2015 Jul 1.
9
Mutations and disorders involving the thyroid iodide transporter--the next wave in thyroid diseases.
J Clin Endocrinol Metab. 1997 Dec;82(12):3964-5. doi: 10.1210/jcem.82.12.4474.
10
VEGFc and VEGFR3 expression in human thyroid pathologies.
Int J Cancer. 2000 Apr 1;86(1):47-52. doi: 10.1002/(sici)1097-0215(20000401)86:1<47::aid-ijc7>3.0.co;2-r.
引用本文的文献
1
Characterization of microRNA-223-3p as a novel promoter of cell proliferation and invasion in papillary thyroid carcinoma.微小RNA-223-3p作为甲状腺乳头状癌中细胞增殖和侵袭新启动子的特征分析
J Cell Commun Signal. 2024 Dec 19;19(1):e12057. doi: 10.1002/ccs3.12057. eCollection 2025 Mar.
2
Clinical-Radiomics Nomogram Based on Contrast-Enhanced Ultrasound for Preoperative Prediction of Cervical Lymph Node Metastasis in Papillary Thyroid Carcinoma.基于超声造影的临床-影像组学列线图对甲状腺乳头状癌颈部淋巴结转移的术前预测
Cancers (Basel). 2023 Mar 5;15(5):1613. doi: 10.3390/cancers15051613.
3
Analysis of factors associated with the prognosis of papillary thyroid cancer and the construction of a survival model.分析影响甲状腺乳头状癌预后的相关因素并构建生存模型。
Cancer Med. 2023 Apr;12(7):7868-7876. doi: 10.1002/cam4.5555. Epub 2022 Dec 22.
4
Trace elements and the thyroid.微量元素与甲状腺。
Front Endocrinol (Lausanne). 2022 Oct 24;13:904889. doi: 10.3389/fendo.2022.904889. eCollection 2022.
5
Risk Factors for Central and Lateral Lymph Node Metastases in Patients With Papillary Thyroid Micro-Carcinoma: Retrospective Analysis on 484 Cases.甲状腺微小乳头状癌中央区与侧颈区淋巴结转移的危险因素：484 例回顾性分析
Front Endocrinol (Lausanne). 2021 Mar 5;12:640565. doi: 10.3389/fendo.2021.640565. eCollection 2021.
6
Cell and Molecular Biology of Thyroid Disorders 2.0.甲状腺疾病的细胞与分子生物学 2.0 版。
Int J Mol Sci. 2021 Feb 17;22(4):1990. doi: 10.3390/ijms22041990.
7
Health-Related Quality of Life in Levothyroxine-Treated Hypothyroid Women and Women without Hypothyroidism: A Case-Control Study.左甲状腺素治疗的甲状腺功能减退女性与非甲状腺功能减退女性的健康相关生活质量：一项病例对照研究。
J Clin Med. 2020 Nov 27;9(12):3864. doi: 10.3390/jcm9123864.
8
Clinicopathological Features as Prognostic Predictors of Poor Outcome in Papillary Thyroid Carcinoma.甲状腺乳头状癌的临床病理特征作为预后不良的预测指标
Cancers (Basel). 2020 Oct 29;12(11):3186. doi: 10.3390/cancers12113186.
9
Toll-Like Receptors-2 and -4 in Graves' Disease-Key Players or Bystanders?TLR2 和 TLR4 在格雷夫斯病中的作用——关键因素还是旁观者？
Int J Mol Sci. 2019 Sep 24;20(19):4732. doi: 10.3390/ijms20194732.
本文引用的文献
1
Fighting Thyroid Cancer with Microgravity Research.利用微重力研究对抗甲状腺癌。
Int J Mol Sci. 2019 May 24;20(10):2553. doi: 10.3390/ijms20102553.
2
Mortalin (GRP75/HSPA9) Promotes Survival and Proliferation of Thyroid Carcinoma Cells.线粒体蛋白（GRP75/HSPA9）促进甲状腺癌细胞的存活和增殖。
Int J Mol Sci. 2019 Apr 26;20(9):2069. doi: 10.3390/ijms20092069.
3
Promoter Hypomethylation as Recurrence Predictive Marker in Well-Differentiated Thyroid Carcinomas.启动子低甲基化作为分化型甲状腺癌复发的预测标志物。
Int J Mol Sci. 2019 Mar 16;20(6):1334. doi: 10.3390/ijms20061334.
4
MiR-19a Overexpression in FTC-133 Cell Line Induces a More De-Differentiated and Aggressive Phenotype.FTC-133 细胞系中 miR-19a 的过表达诱导更去分化和侵袭的表型。
Int J Mol Sci. 2018 Dec 7;19(12):3944. doi: 10.3390/ijms19123944.
5
Pazopanib, Cabozantinib, and Vandetanib in the Treatment of Progressive Medullary Thyroid Cancer with a Special Focus on the Adverse Effects on Hypertension.帕唑帕尼、卡博替尼和凡德他尼在进展性甲状腺髓样癌治疗中的应用，特别关注对高血压的不良反应。
Int J Mol Sci. 2018 Oct 20;19(10):3258. doi: 10.3390/ijms19103258.
6
OPNa Overexpression Is Associated with Matrix Calcification in Thyroid Cancer Cell Lines.OPNa 过表达与甲状腺癌细胞系中的基质钙化有关。
Int J Mol Sci. 2018 Sep 30;19(10):2990. doi: 10.3390/ijms19102990.
7
Metabolomic Alterations in Thyrospheres and Adherent Parental Cells in Papillary Thyroid Carcinoma Cell Lines: A Pilot Study.甲状腺癌细胞系中甲状腺球体和贴壁亲本细胞的代谢组学改变：一项初步研究。
Int J Mol Sci. 2018 Sep 27;19(10):2948. doi: 10.3390/ijms19102948.
8
Whole Exome Sequencing Identifies a Novel Hedgehog-Interacting Protein G516R Mutation in Locally Advanced Papillary Thyroid Cancer.全外显子组测序鉴定局部晚期甲状腺乳头状癌中新型 Hedgehog 相互作用蛋白 G516R 突变。
Int J Mol Sci. 2018 Sep 21;19(10):2867. doi: 10.3390/ijms19102867.
9
Glycosylation in the Thyroid Gland: Vital Aspects of Glycoprotein Function in Thyrocyte Physiology and Thyroid Disorders.甲状腺中的糖基化：糖蛋白在甲状腺细胞生理学和甲状腺疾病中的功能的重要方面。
Int J Mol Sci. 2018 Sep 17;19(9):2792. doi: 10.3390/ijms19092792.
10
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.全球癌症统计数据 2018：GLOBOCAN 对全球 185 个国家/地区 36 种癌症的发病率和死亡率的估计。
CA Cancer J Clin. 2018 Nov;68(6):394-424. doi: 10.3322/caac.21492. Epub 2018 Sep 12.
Zotero 插件